ABSTRACT SUBMITTALS
Abstracts are invited for consideration for the Tissue Engineering & Regenerative Medicine International Society
- TERMIS-North America 2010 Conference and Exposition, December 5 - 8, 2010, Hilton in the WALT DISNEY WORLDŽ Resort, Orlando, Florida.
The TERMIS NA 2010 Conference will feature an outstanding scientific and business program and an industry-focused trade show bringing
together national and international communities of scientists, clinicians, students, business leaders, entrepreneurs, and representatives
of government funding agencies engaged or interested in the fields of cellular therapies, medical devices and artificial organs,
biomaterials, bioengineering and clinical translation.
The goals: Present and exchange new results and advances in tissue engineering and regenerative medicine, discuss their context
and enhance interactions, ultimately benefiting patients worldwide.
This collaboration will enable a dynamic event, tapping cross-organization talent, and offering the presenters an opportunity to discuss
their research and clinical successes with a broad audience. The TERMIS NA 2010 scientific program will focus on tissue
engineering/regenerative medicine approaches to restoring the function of damaged or diseased tissues and organs leading to clinical
applications and commercial advances. Concurrently, the program will feature platform/enabling technologies and many of the broader
cross-cutting challenges facing this emerging field of biomedicine.
Experts from academia and commerce are invited to present timely information ranging from cutting edge research to successful implementation
of tissue engineering technologies in all areas of tissue engineering/regenerative medicine including:
- Stem Cells in Regenerative Medicine
- Biomaterial-based Tissue Regeneration
- Controlling Microenvironment and Cell Fate
- Nanobiotechnology for Regenerative Medicine
- Cell Tracking and Imaging
- Biomaterials Fabrication and Synthesis
- Bioreactor Technologies
- Immunology and Tissue Responses in Regenerative Medicine
- Regeneration by Endogenous Cell Homing
- Functionalization of Cells and Biomaterials
- Digital Biofabrication
- Cardiac Tissue Regeneration
- Soft Tissue Repair
- Skin and Wound Healing
- Endocrine System
- Angiogenesis and Vascular Tissue Engineering
- Cartilage Tissue Engineering
- Neural Tissue Engineering
- Urologic Tissue
- Liver Tissue Regeneration
- Musculoskeletal Tissue Engineering
- Craniofacial and Dental Tissue Engineering
- Tissue Engineering and Regenerative Medicine in the Clinic
- International Regulatory Harmonization
- Large Scale Automation for Cell Therapy
- Addressing Challenges in Regenerative Medicine
- Cancer and Regenerative Medicine
- Future of Regenerative Medicine; Industry Perspective
- Biopreservation
Review Criteria and Selection of Abstracts (show more)
The most innovative and promising basic, applied and clinical research within these topical areas will be presented in 15-minute
oral presentations within specific tracks. Abstracts based on new research that has not been presented or published elsewhere
will be given primary consideration.
Abstracts will be reviewed by the Scientific Advisory Committee and Session chairs and evaluated based on the following criteria:
- Contribution and relevance to the field of tissue engineering/regenerative medicine and the literature
- Quality of scientific content
- Originality of research
- Previous presentation or publication
- Adherence to required format
Note:
- Some research is more appropriately presented in poster format. Preference for oral presentations will be given to those abstracts that are likely to stimulate broad scientific discussion.
- Abstracts that are not supported by full technical disclosure or are promotional rather than scientific in nature are discouraged.
- The final selection of abstracts and determinations of oral/poster format will be made by the Scientific Advisory Committee and Session Chairs and is not subject to appeal.
- Abstracts will be submitted for inclusion in conference proceedings (online materials).
- Common reasons for abstract rejection are:
- Poorly supported research hypothesis/objective/rationale
- Experimental plan vague and/or not well documented/described
- Insufficient data collected
- Poor analysis of the data
- Conclusions not supported by the results
- Poor grammar/figures/tables
Abstract Content (show more)
The abstract should clearly describe the nature of the research and the problem it addresses, and be presented in such language
as to be understood by scientists representing the multi-disciplinary nature of tissue engineering. The abstract should summarize
the objectives of the research, the methodology employed, results,
and their significance.
Content should be organized as follows:
- Introduction, including hypothesis and objectives
- Materials and Methods
- Results, in appropriate detail
- Discussion and Conclusions
- References, to key literature
Abstract Preparation
A sample abstract is available at this link:
View a sample abstract.
Oral or Poster Preference
The preferred method of presentation (oral or poster) should be noted on the online submission form. Your preference will be
noted by the reviewers. Final determination will be made by the Scientific Advisory Committee.
Abstract Format (show more)
General Issues: Each published abstract is required to fit on ONE 8.5" x 11" page and to be
transmitted in either Microsoft Word or Adobe Acrobat (either *.doc or *.pdf) file type. The abstract should be formatted in
two columns (3.25" columns, 0.75" inch margins all around, 0.5" between columns), inclusive of tables, graphs, or pictures,
with all text in Times New Roman 10 point type with single line spacing.
Submission instructions are also available on the TERMIS NA 2010 website: www.termis.org/na2010 and adherence will be required to
upload your original Word or Adobe document.
File size should not exceed 3 MB.
Title: Title should be brief, clearly indicating the nature of the presentation. Title should be in bold font
and mixed case font followed by a single return. Do not put a period at the end of the title.
Example for Title: This is a Properly Formatted Abstract Title
Author(s): In upper and lower case letters as follows: First Name, Middle Initial Last Name of each author (underline
the name of the presenting author) with the corresponding institution of the author's. Follow with a single return.
** Presenting authors are expected to pay their own travel expenses and conference registration fee(s).
Complete contact information (name, mailing address, and e-mail) for each author listed on the abstract must be entered before submitting
the abstract file.
Tables and Graphs: Supporting graphs, tables and other graphics and specific data that will illustrate and/or clarify the
research and its impacts are encouraged. These graphs, tables and graphics should be embedded in the submitted Word document and must be
of sufficient resolution to be reproduced clearly, typically at 300 dpi.
References: May be included at the end. Please use a standard format, such as that shown below:
References:
1. Langer R, Vacanti JP. Tissue Engineering. Science 260, 920, 1993.
Acknowledgments: Support from outside sources, such as Research Grants, should be listed here. Based on the standards set
by the Accreditation Council for Continuing Medical Education and guidelines of the Food and Drug Administration as endorsed by the
American Medical Association, any conflict of interest must be clearly recognizable. The indication of outside support does not affect the
decision of abstract acceptance or rejection.
Disclosures: Include any disclosure information here. In order for your colleagues to properly evaluate the information,
analysis and opinions presented in your abstract, it is important that they be informed of potential conflicts of interest pertinent to the
research submitted. Therefore, conference management requires that all authors provide any relevant information concerning personal or
professional circumstances and relationships that might reasonably be expected to affect the author's view on the subject. Examples include,
but are not limited to:
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Employment (full or part-time)
- Ownership or partnership
- Consulting fees or other remuneration (payment)
- Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
- Receipt of royalties
- Speakers bureau
Appropriate disclosure will be stated in the scientific program and the abstract volume. If you do not have anything to disclose, you must
indicate this on the online abstract submission form. The disclosure information you provide will not influence the review of your abstract.
Abstracts will not be reviewed without proper completion of the disclosure section on the abstract submission form. Disclosure information for
all authors is required upon abstract submission.
Submission Deadline
Deadline for abstracts is August 10, 2010.
You will receive an email confirmation upon completion of submitting an abstract.
Online Revisions
You may revise your abstract no later than 11:59 pm Eastern Daylight Time on Tuesday, August 10, 2010, 2010 by returning to the site and
logging in again.
You will need your email name to login and your personal key code which is provided in your submission confirmation e-mail message. After
the deadline, all completed abstracts in the system will be sent to the Abstract Reviewers for review. Any abstracts left "incomplete" will not
be sent for review. There are no exceptions.
Abstract Withdrawals
If the abstract must be withdrawn, the TERMIS NA office must be notified in writing at least ONE month prior to the meeting via e-mail to
Andrea Lubienski at alubienski@conferencestrategists.com
NOTE: All presenters are expected to cover their own travel and lodging expenses and pay the conference registration fees.
Notification Deadline
Notification of acceptance for oral and poster presentations will be made by September 10, 2010.
Registration Requirements
Accepted authors are expected to pay their own travel expenses and conference registration fee(s).
Dates of presentation cannot be guaranteed.
For More Information
For more information on abstract content, format and submission procedure, contact:
Andrea Lubienski
Forecast Technology Group, Inc.
alubienski@conferencestrategists.com
